Literature DB >> 21080519

Alemtuzumab treatment for hemophagocytic lymphohistiocytosis.

Maciej Machaczka, Johan Vaktnäs, Samuel C C Chiang, Yenan T Bryceson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21080519     DOI： 10.1038/nrclinonc.2010.40-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children.

Authors:  Herwig Lackner; Christian Urban; Petra Sovinz; Martin Benesch; Andrea Moser; Wolfgang Schwinger
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

3.  Fever, shock, and pancytopenia in a patient treated with alemtuzumab.

Authors:  Martijn P Bauer; Nathalie D van Burgel; W A Erik Marijt; Jaap T van Dissel; Peter A von dem Borne
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

4.  Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.

Authors:  Matthew P Strout; Stuart Seropian; Nancy Berliner
Journal:  Nat Rev Clin Oncol       Date:  2010-04-20       Impact factor: 66.675

Review 5.  Hemophagocytic lymphohistiocytosis: when the immune system runs amok.

Authors:  G Janka
Journal:  Klin Padiatr       Date:  2009-08-25       Impact factor: 1.349

Review 6.  Chronic lymphocytic leukemia: treatment options for patients with refractory disease.

Authors:  Marina Motta; William G Wierda; Alessandra Ferrajoli
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

7.  Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

Authors:  Eiichi Ishii; Shouichi Ohga; Shinsaku Imashuku; Masaki Yasukawa; Hiroyuki Tsuda; Ikuo Miura; Ken Yamamoto; Hisanori Horiuchi; Kenzo Takada; Koichi Ohshima; Shigeo Nakamura; Naoko Kinukawa; Kazuo Oshimi; Keisei Kawa
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490
  7 in total
  3 in total

Review 1.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Authors:  Sebastian Fn Bode; Kai Lehmberg; Andrea Maul-Pavicic; Thomas Vraetz; Gritta Janka; Udo Zur Stadt; Stephan Ehl
Journal:  Arthritis Res Ther       Date:  2012-06-08       Impact factor: 5.156

Review 2.  Hemophagocytic syndrome in children and adults.

Authors:  Iwona Malinowska; Maciej Machaczka; Katarzyna Popko; Alicja Siwicka; Małgorzata Salamonowicz; Barbara Nasiłowska-Adamska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-09       Impact factor: 4.291

Review 3.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.